Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary S Gottesman

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Clinical Pediatrics|August 18, 2022
Diagnosing X-Linked Hypophosphatemia in Children: The Missing ElementGary S Gottesman
Missouri Medicine|May 4, 2004
The challenges of medical genetics and the primary care practitionerGary S Gottesman
JAAPA : Official Journal of the American Academy of Physician Assistants|March 18, 2010
The genetics encounter: different from the typical clinic visitGary S Gottesman
Missouri Medicine|May 31, 2012
Newborn metabolic screening and related pitfallsMark Eddy, Gary S Gottesman
JAAPA : Official Journal of the American Academy of Physician Assistants|April 24, 2010
Newborn screening tests in the 21st century: what PAs need to knowGenevieve DelRosario, Gary S Gottesman
JAAPA : Official Journal of the American Academy of Physician Assistants|January 26, 2011
Mystery solved: The evolution of diagnostic abilities in genetic testingGary S Gottesman, Jacqueline R Batanian
Pediatrics in Review|November 30, 2024
A 2-year-old Girl with Poor Growth and Inability to StandMargaret Urschler, Gary S Gottesman, Brian R Stotter
American Journal of Medical Genetics. Part A|January 15, 2016
Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget diseaseGary S Gottesman, Katherine L Madson, William H McAlister, et al.
Journal of Pediatric Orthopedics|March 23, 2023
Predicting Rates of Angular Correction After Hemiepiphysiodesis in Patients With X-Linked Hypophosphatemic RicketsCaleb W Grote, Jeffrey J Nepple, Perry L Schoenecker, et al.
The Lancet. Diabetes & Endocrinology|January 15, 2019
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trialMichael P Whyte, Thomas O Carpenter, Gary S Gottesman, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Clinical Pediatrics|August 18, 2022
Diagnosing X-Linked Hypophosphatemia in Children: The Missing ElementGary S Gottesman
Missouri Medicine|May 4, 2004
The challenges of medical genetics and the primary care practitionerGary S Gottesman
JAAPA : Official Journal of the American Academy of Physician Assistants|March 18, 2010
The genetics encounter: different from the typical clinic visitGary S Gottesman
Missouri Medicine|May 31, 2012
Newborn metabolic screening and related pitfallsMark Eddy, Gary S Gottesman
JAAPA : Official Journal of the American Academy of Physician Assistants|April 24, 2010
Newborn screening tests in the 21st century: what PAs need to knowGenevieve DelRosario, Gary S Gottesman
JAAPA : Official Journal of the American Academy of Physician Assistants|January 26, 2011
Mystery solved: The evolution of diagnostic abilities in genetic testingGary S Gottesman, Jacqueline R Batanian
Pediatrics in Review|November 30, 2024
A 2-year-old Girl with Poor Growth and Inability to StandMargaret Urschler, Gary S Gottesman, Brian R Stotter
American Journal of Medical Genetics. Part A|January 15, 2016
Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget diseaseGary S Gottesman, Katherine L Madson, William H McAlister, et al.
Journal of Pediatric Orthopedics|March 23, 2023
Predicting Rates of Angular Correction After Hemiepiphysiodesis in Patients With X-Linked Hypophosphatemic RicketsCaleb W Grote, Jeffrey J Nepple, Perry L Schoenecker, et al.
The Lancet. Diabetes & Endocrinology|January 15, 2019
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trialMichael P Whyte, Thomas O Carpenter, Gary S Gottesman, et al.
Pageof 4